Inhibrx Biosciences Inc. logo

Inhibrx Biosciences Inc.

INBX | NASDAQ
Chart Builder DCF Calculator
$111.42
-$0.62 (-0.55%)
Sep 22, 2026, 12:03 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
124.22M 152.6M 277.92M 273.87M 131.3M 128.66M
Short-Term Investments
n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
4.38M 6.83M 3.16M 3.16M 1.85M 245K
Receivables
177K 420K 778K 257K 878K 615K
Inventory
n/a n/a n/a n/a -878K -129.28M
Other Current Assets
238K 816K 728K 181K 7.81M 132.17M
Total Current Assets
132.83M 160.4M 295.36M 280.49M 139.11M 132.17M
Property-Plant & Equipment
9.27M 13.54M 9.37M 7.22M 9.49M 11.32M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
13.65M 20.37M 12.54M 10.38M 11.34M 11.57M
Total Assets
146.48M 180.77M 307.89M 290.88M 150.45M 143.74M
Account Payables
5.94M 9.25M 10.95M 8.33M 9.13M 13.46M
Deferred Revenue
n/a n/a n/a 166K 2.03M 3.08M
Short-Term Debt
2.33M 1.6M n/a 1.86M 1.67M 1.5M
Other Current Liabilities
18.08M 7.73M 6.51M 13.85M 9.62M 13.36M
Total Current Liabilities
33.8M 40.73M 56.31M 27.58M 22.45M 31.4M
Long-Term Debt
100.56M n/a 206.97M 202.07M 70.47M 35.95M
Other Long-Term Liabilities
n/a n/a n/a n/a 5.03M 180K
Total Long-Term Liabilities
104.69M 6.45M 208.08M 205.24M 75.61M 36.87M
Total Liabilities
138.49M 47.18M 264.39M 232.82M 98.07M 68.27M
Total Debt
107.01M 8.05M 210.14M 207.1M 72.14M 37.45M
Book Value
7.99M 133.58M 43.5M 58.06M 52.38M 75.47M
Book Value Per Share
0.52 9.23 0.92 1.45 1.38 2.99
Common Stock
1K 1K 5K 4K 4K 4K
Retained Earnings
-246.19M -106.13M -613.73M -372.37M -227.15M -145.38M
Comprehensive Income
n/a n/a n/a n/a -150.45M -143.74M
Shareholders Equity
7.99M 133.58M 43.5M 58.06M 52.38M 75.47M
Total Investments
n/a n/a n/a n/a n/a n/a

© 2026 bestshares.com. All rights reserved.